{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T19:54:15Z","timestamp":1787774055575,"version":"build-2784847793"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T00:00:00Z","timestamp":1763683200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T00:00:00Z","timestamp":1763683200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurosurg Rev"],"DOI":"10.1007\/s10143-025-03945-9","type":"journal-article","created":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T07:53:04Z","timestamp":1763711584000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Potential for multidrug combination therapy in patients with World Federation of Neurological Surgeons grade V subarachnoid hemorrhage"],"prefix":"10.1007","volume":"49","author":[{"given":"Fuki","family":"Goto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumihiro","family":"Kawakita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichi","family":"Hakozaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuaki","family":"Aoki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8555-5448","authenticated-orcid":false,"given":"Hidenori","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"pSEED group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Sakaida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuyuki","family":"Umeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsuhiro","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoichi","family":"Miura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Kamei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takanori","family":"Sano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomohiro","family":"Araki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masato","family":"Shiba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoki","family":"Ichikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigetoshi","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuro","family":"Tsuchiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reona","family":"Asada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoki","family":"Toma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryuta","family":"Yasuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshinari","family":"Nakatsuka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirofumi","family":"Nishikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideki","family":"Kanamaru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yotaro","family":"Kitano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fujimaro","family":"Ishida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiji","family":"Fukazawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoru","family":"Tanioka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhiko","family":"Tsuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroto","family":"Murata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhide","family":"Hamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumitaka","family":"Miya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Tanemura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masashi","family":"Fujimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,21]]},"reference":[{"key":"3945_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jstrokecerebrovasdis.2025.108296","volume":"34","author":"R Ando-Matsuoka","year":"2025","unstructured":"Ando-Matsuoka R, Kawada K, Niimura T, Fukuda H, Ishida T, Yoshioka T, Kawanishi Y, Kadota T, Abe S, Aizawa F, Yagi K, Izawa-Ishizawa Y, Goda M, Ueba T, Ishizawa K (2025) Risk factors for clazosentan-induced fluid retention in subarachnoid hemorrhage from the Japanese adverse event database. J Stroke Cerebrovasc Dis 34:108296. https:\/\/doi.org\/10.1016\/j.jstrokecerebrovasdis.2025.108296","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"3945_CR2","doi-asserted-by":"publisher","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","volume":"57","author":"Y Benjamini","year":"1995","unstructured":"Benjamini Y, Hochberg Y (1995) Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Series B Stat Methodol 57:289\u2009\u2212\u2009300. https:\/\/doi.org\/10.1111\/j.2517-6161.1995.tb02031.x","journal-title":"J R Stat Soc Series B Stat Methodol"},{"key":"3945_CR3","doi-asserted-by":"publisher","first-page":"3333","DOI":"10.1007\/s00330-016-4702-y","volume":"27","author":"G Boulouis","year":"2017","unstructured":"Boulouis G, Labeyrie MA, Raymond J, Rodriguez-R\u00e9gent C, Lukaszewicz AC, Bresson D, Ben Hassen W, Trystram D, Meder JF, Oppenheim C, Naggara O (2017) Treatment of cerebral vasospasm following aneurysmal subarachnoid haemorrhage: a systematic review and meta-analysis. Eur Radiol 27:3333\u20133342. https:\/\/doi.org\/10.1007\/s00330-016-4702-y","journal-title":"Eur Radiol"},{"key":"3945_CR4","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.3171\/2022.2.JNS212914","volume":"137","author":"H Endo","year":"2022","unstructured":"Endo H, Hagihara Y, Kimura N, Takizawa K, Niizuma K, Togo O, Tominaga T (2022) Effects of Clazosentan on cerebral vasospasm-related morbidity and all-cause mortality after aneurysmal subarachnoid hemorrhage: two randomized phase 3 trials in Japanese patients. J Neurosurg 137:1707\u20131717. https:\/\/doi.org\/10.3171\/2022.2.JNS212914","journal-title":"J Neurosurg"},{"key":"3945_CR5","doi-asserted-by":"publisher","unstructured":"Frontera JA, Claassen J, Schmidt JM, Wartenberg KE, Temes R, Connolly ES Jr, MacDonald RL, Mayer SA (2006) Prediction of symptomatic vasospasm after subarachnoid hemorrhage: the modified fisher scale. Neurosurgery 59:21\u201327. https:\/\/doi.org\/10.1227\/01.neu.0000243277.86222.6c","DOI":"10.1227\/01.neu.0000243277.86222.6c"},{"key":"3945_CR6","doi-asserted-by":"publisher","DOI":"10.3390\/jcm14082715","volume":"14","author":"K Hakozaki","year":"2025","unstructured":"Hakozaki K, Kawakita F, Aoki K, Suzuki H, pSEED Group (2025) Spinal drainage and combined pharmacotherapy as potential strategies to improve outcomes for patients with poor-grade subarachnoid hemorrhage treated with clipping or coiling but not receiving nimodipine. J Clin Med 14:2715. https:\/\/doi.org\/10.3390\/jcm14082715","journal-title":"J Clin Med"},{"key":"3945_CR7","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1161\/STROKEAHA.116.014250","volume":"48","author":"D H\u00e4nggi","year":"2017","unstructured":"H\u00e4nggi D, Etminan N, Aldrich F, Steiger HJ, Mayer SA, Diringer MN, Hoh BL, Mocco J, Faleck HJ, Macdonald RL, NEWTON I (2017) Randomized, open-label, phase 1\/2a study to determine the maximum tolerated dose of intraventricular sustained release nimodipine for subarachnoid hemorrhage (NEWTON [nimodipine microparticles to enhance recovery while reducing toxicity after subarachnoid hemorrhage]). Stroke 48:145\u2013151. https:\/\/doi.org\/10.1161\/STROKEAHA.116.014250","journal-title":"Stroke"},{"key":"3945_CR8","doi-asserted-by":"publisher","first-page":"4107","DOI":"10.3390\/jcm14124107","volume":"14","author":"T Hidaka","year":"2025","unstructured":"Hidaka T, Ochiai J, Inoue Y, Kawamoto Y, Horie N, Nishikawa Y, Mase M, Morioka M, Takahashi JC, Shimizu H, Ikawa F (2025) Japanese nationwide questionnaire survey on the treatment and management of subarachnoid hemorrhage due to ruptured cerebral aneurysm. J Clin Med 14:4107. https:\/\/doi.org\/10.3390\/jcm14124107","journal-title":"J Clin Med"},{"key":"3945_CR9","doi-asserted-by":"publisher","first-page":"e314","DOI":"10.1161\/STR.0000000000000436","volume":"54","author":"BL Hoh","year":"2023","unstructured":"Hoh BL, Ko NU, Amin-Hanjani S, Chou SH-Y, Cruz-Flores S, Dangayach NS, Derdeyn CP, Du R, H\u00e4nggi D, Hetts SW, Ifejika NL, Johnson R, Keigher KM, Leslie-Mazwi TM, Lucke-Wold B, Rabinstein AA, Robicsek SA, Stapleton CJ, Suarez JI, Tjoumakaris SI, Welch BG (2023) 2023 guideline for the management of patients with aneurysmal subarachnoid hemorrhage: a guideline from the American heart association\/American stroke association. Stroke 54:e314\u2013e370. https:\/\/doi.org\/10.1161\/STR.0000000000000436","journal-title":"Stroke"},{"key":"3945_CR10","doi-asserted-by":"publisher","first-page":"e216","DOI":"10.1016\/j.wneu.2022.05.135","volume":"165","author":"S Hori","year":"2022","unstructured":"Hori S, Kashiwazaki D, Akioka N, Okamoto S, Kubo M, Horie Y, Kuwayama N, Kuroda S (2022) Predictive factors of functional outcome in world federation of neurosurgical societies grade V subarachnoid hemorrhage. World Neurosurg 165:e216\u2013e222. https:\/\/doi.org\/10.1016\/j.wneu.2022.05.135","journal-title":"World Neurosurg"},{"key":"3945_CR11","doi-asserted-by":"publisher","first-page":"29","DOI":"10.2176\/jns-nmc.2024-0204","volume":"65","author":"S Kajiwara","year":"2025","unstructured":"Kajiwara S, Kawano T, Hasegawa Y, Nakamura Y, Sakata K, Kikuchi J, Hirohata M, Morioka M (2025) Impact of Clazosentan on vasospasm reduction and functional recovery after aneurysmal subarachnoid hemorrhage. Neurol Med Chir (Tokyo) 65:29\u201336. https:\/\/doi.org\/10.2176\/jns-nmc.2024-0204","journal-title":"Neurol Med Chir (Tokyo)"},{"key":"3945_CR12","doi-asserted-by":"publisher","first-page":"100","DOI":"10.3171\/2016.8.JNS161075","volume":"128","author":"J Konczalla","year":"2018","unstructured":"Konczalla J, Seifert V, Beck J, G\u00fcresir E, Vatter H, Raabe A, Marquardt G (2018) Outcome after Hunt and Hess grade V subarachnoid hemorrhage: a comparison of pre-coiling era (1980\u20131995) versus post-ISAT era (2005\u20132014). J Neurosurg 128:100\u2013110. https:\/\/doi.org\/10.3171\/2016.8.JNS161075","journal-title":"J Neurosurg"},{"key":"3945_CR13","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1007\/s00701-019-04190-y","volume":"162","author":"A Lashkarivand","year":"2020","unstructured":"Lashkarivand A, Sorteberg W, Rosseland LA, Sorteberg A (2020) Survival and outcome in patients with aneurysmal subarachnoid hemorrhage in Glasgow coma score 3\u20135. Acta Neurochir (Wien) 162:533\u2013544. https:\/\/doi.org\/10.1007\/s00701-019-04190-y","journal-title":"Acta Neurochir (Wien)"},{"key":"3945_CR14","doi-asserted-by":"publisher","first-page":"e2160","DOI":"10.1038\/cddis.2016.63","volume":"7","author":"C Luo","year":"2016","unstructured":"Luo C, Yao X, Li J, He B, Liu Q, Ren H, Liang F, Li M, Lin H, Peng J, Yuan TF, Pei Z, Su H (2016) Paravascular pathways contribute to vasculitis and neuroinflammation after subarachnoid hemorrhage independently of glymphatic control. Cell Death Dis 7:e2160. https:\/\/doi.org\/10.1038\/cddis.2016.63","journal-title":"Cell Death Dis"},{"key":"3945_CR15","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000042544","volume":"104","author":"H Magara","year":"2025","unstructured":"Magara H, Tani T, Imai S, Yoshida K, Fushimi K, Sugiura M (2025) Prognosis of patients with aneurysmal subarachnoid hemorrhage treated with fasudil hydrochloride-cilostazol combination therapy: a cross-sectional analysis of a nationwide inpatient database, 2016 to 2020. Medicine (Baltimore) 104:e42544. https:\/\/doi.org\/10.1097\/MD.0000000000042544","journal-title":"Medicine (Baltimore)"},{"key":"3945_CR16","doi-asserted-by":"publisher","first-page":"98","DOI":"10.3171\/2024.4.JNS232191","volume":"142","author":"SA Mayer","year":"2024","unstructured":"Mayer SA, Bruder N, Citerio G, Defreyne L, Dubois C, Gupta R, Higashida R, Marr A, Nguyen TN, Roux S, Smr\u010dka M, Torn\u00e9 RT, Aldrich EF (2024) REACT: a randomized trial to assess the efficacy and safety of clazosentan for preventing clinical deterioration due to delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage. J Neurosurg 142:98\u2013109. https:\/\/doi.org\/10.3171\/2024.4.JNS232191","journal-title":"J Neurosurg"},{"key":"3945_CR17","doi-asserted-by":"publisher","DOI":"10.3171\/2025.1.JNS242509","author":"S Muraoka","year":"2025","unstructured":"Muraoka S, Izumi T, Nishida K, Chr\u00e9tien B, Ishii K, Takeuchi I, Nishihori M, Goto S, Maesawa S, Shimato S, Kinkori T, Asai T, Suzuki O, Saito R (2025) RECOVER study: a multicenter retrospective cohort study and comparison of the efficacy and safety of Clazosentan and fasudil in patients with aneurysmal subarachnoid hemorrhage. J Neurosurg. https:\/\/doi.org\/10.3171\/2025.1.JNS242509","journal-title":"J Neurosurg"},{"key":"3945_CR18","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/j.wneu.2016.12.018","volume":"99","author":"I Nakagawa","year":"2017","unstructured":"Nakagawa I, Yokoyama S, Omoto K, Takeshima Y, Matsuda R, Nishimura F, Yamada S, Yokota H, Motoyama Y, Park YS, Nakase H (2017) \u03c9-3 fatty acids Ethyl esters suppress cerebral vasospasm and improve clinical outcome following aneurysmal subarachnoid hemorrhage. World Neurosurg 99:457\u2013464. https:\/\/doi.org\/10.1016\/j.wneu.2016.12.018","journal-title":"World Neurosurg"},{"key":"3945_CR19","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1007\/s10143-024-02795-1","volume":"47","author":"H Nakajima","year":"2024","unstructured":"Nakajima H, Kawakita F, Okada T, Oinaka H, Suzuki Y, Nampei M, Kitano Y, Nishikawa H, Fujimoto M, Miura Y, Yasuda R, Toma N, Suzuki H (2024) Treatment factors to suppress delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage based on VASOGRADE: multicenter cohort study. Neurosurg Rev 47:564. https:\/\/doi.org\/10.1007\/s10143-024-02795-1","journal-title":"Neurosurg Rev"},{"key":"3945_CR20","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.hest.2024.02.001","volume":"5","author":"M Nampei","year":"2024","unstructured":"Nampei M, Kawakita F, Asada R, Suzuki Y, Nakajima H, Oinaka H, Suzuki H, pSEED G (2024) Increased plasma pigment epithelium-derived factor (PEDF) concentrations as a negative predictor of angiographic vasospasm after aneurysmal subarachnoid hemorrhage. Brain Hemorrhages 5:169\u2013176. https:\/\/doi.org\/10.1016\/j.hest.2024.02.001","journal-title":"Brain Hemorrhages"},{"key":"3945_CR21","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1007\/s12975-024-01308-y","volume":"16","author":"M Naraoka","year":"2025","unstructured":"Naraoka M, Shimamura N, Ohkuma H (2025) Cilostazol alleviates delayed cerebral ischemia after subarachnoid hemorrhage by attenuating microcirculatory dysfunction. Transl Stroke Res 16:1285\u20131292. https:\/\/doi.org\/10.1007\/s12975-024-01308-y","journal-title":"Transl Stroke Res"},{"key":"3945_CR22","doi-asserted-by":"publisher","first-page":"1296995","DOI":"10.3389\/fneur.2023.1296995","volume":"14","author":"Y Nishikawa","year":"2023","unstructured":"Nishikawa Y, Yamada S, Uchida M, Yamanaka T, Hayashi Y, Katano H, Tanikawa M, Iwama T, Iihara K, Morioka M, Mase M (2023) Japanese nationwide questionnaire survey on delayed cerebral infarction due to vasospasm after subarachnoid hemorrhage. Front Neurol 14:1296995. https:\/\/doi.org\/10.3389\/fneur.2023.1296995","journal-title":"Front Neurol"},{"key":"3945_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.hest.2023.12.003","volume":"5","author":"H Oinaka","year":"2024","unstructured":"Oinaka H, Kawakita F, Nakajima H, Suzuki Y, Nampei M, Okada T, Yasuda R, Toma N, Suzuki H, pSEED G (2024) Increased plasma Periostin concentration predicts angiographic vasospasm development in non-severe aneurysmal subarachnoid hemorrhage. Brain Hemorrhages 5:1\u20137. https:\/\/doi.org\/10.1016\/j.hest.2023.12.003","journal-title":"Brain Hemorrhages"},{"key":"3945_CR24","doi-asserted-by":"publisher","first-page":"e79497","DOI":"10.7759\/cureus.79497","volume":"17","author":"E Okumura","year":"2025","unstructured":"Okumura E, Nakaya K, Otsuka K, Jimbo H (2025) Treatment outcomes of Clazosentan use during the perioperative period for subarachnoid hemorrhage. Cureus 17:e79497. https:\/\/doi.org\/10.7759\/cureus.79497","journal-title":"Cureus"},{"key":"3945_CR25","doi-asserted-by":"publisher","first-page":"505","DOI":"10.3171\/jns.1988.68.4.0505","volume":"68","author":"KC Petruk","year":"1988","unstructured":"Petruk KC, West M, Mohr G, Weir BK, Benoit BG, Gentili F, Disney LB, Khan MI, Grace M, Holness RO, Karwon MS, Ford RM, Cameron GS, Tucker WS, Purves GB, Miller JDR, Hunter KM, Richard MT, Durity FA, Chan R, Clein LJ, Maroun FB, Godon A (1988) Nimodipine treatment in poor-grade aneurysm patients. Results of a multicenter double-blind placebo-controlled trial. J Neurosurg 68:505\u2013517. https:\/\/doi.org\/10.3171\/jns.1988.68.4.0505","journal-title":"J Neurosurg"},{"key":"3945_CR26","doi-asserted-by":"publisher","first-page":"1413632","DOI":"10.3389\/fneur.2024.1413632","volume":"15","author":"H Sakata","year":"2024","unstructured":"Sakata H, Kanoke A, Uchida H, Haryu S, Omodaka S, Kimura N, Yoshida M, Niizuma K, Tominaga T, Endo H (2024) Prophylactic management of cerebral vasospasm with Clazosentan in real clinical practice: a single-center retrospective cohort study. Front Neurol 15:1413632. https:\/\/doi.org\/10.3389\/fneur.2024.1413632","journal-title":"Front Neurol"},{"key":"3945_CR27","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1007\/s12975-018-0650-y","volume":"10","author":"H Suzuki","year":"2019","unstructured":"Suzuki H, Nakatsuka Y, Yasuda R, Shiba M, Miura Y, Terashima M, Suzuki Y, Hakozaki K, Goto F, Toma N (2019) Dose-dependent inhibitory effects of cilostazol on delayed cerebral infarction after aneurysmal subarachnoid hemorrhage. Transl Stroke Res 10:381\u2013388. https:\/\/doi.org\/10.1007\/s12975-018-0650-y","journal-title":"Transl Stroke Res"},{"key":"3945_CR28","doi-asserted-by":"publisher","first-page":"143","DOI":"10.14670\/HH-18-253","volume":"36","author":"H Suzuki","year":"2021","unstructured":"Suzuki H, Kanamaru H, Kawakita F, Asada R, Fujimoto M, Shiba M (2021) Cerebrovascular pathophysiology of delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage. Histol Histopathol 36:143\u2013158. https:\/\/doi.org\/10.14670\/HH-18-253","journal-title":"Histol Histopathol"},{"key":"3945_CR29","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23063102","volume":"23","author":"H Suzuki","year":"2022","unstructured":"Suzuki H, Kawakita F, Asada R (2022) Neuroelectric mechanisms of delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage. Int J Mol Sci 23:3102. https:\/\/doi.org\/10.3390\/ijms23063102","journal-title":"Int J Mol Sci"},{"key":"3945_CR30","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1007\/s12975-022-01101-9","volume":"14","author":"H Suzuki","year":"2023","unstructured":"Suzuki H, Miura Y, Yasuda R, Yago T, Mizutani H, Ichikawa T, Miyazaki T, Kitano Y, Nishikawa H, Kawakita F, Fujimoto M, Toma N (2023) Effects of new-generation antiepileptic drug prophylaxis on delayed neurovascular events after aneurysmal subarachnoid hemorrhage. Transl Stroke Res 14:899\u2013909. https:\/\/doi.org\/10.1007\/s12975-022-01101-9","journal-title":"Transl Stroke Res"},{"key":"3945_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.clineuro.2024.108634","volume":"247","author":"Y Suzuki","year":"2024","unstructured":"Suzuki Y, Okada T, Oinaka H, Nakajima H, Nampei M, Kawakita F, Suzuki H, pSEED group (2024) Independent elevation of plasma fibulin-5 proceeding chronic hydrocephalus development after aneurysmal subarachnoid hemorrhage. Clin Neurol Neurosurg 247:108634. https:\/\/doi.org\/10.1016\/j.clineuro.2024.108634","journal-title":"Clin Neurol Neurosurg"},{"key":"3945_CR32","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.hest.2023.10.006","volume":"5","author":"H Suzuki","year":"2024","unstructured":"Suzuki H, Nakajima H, Ichikawa T, Yasuda R, Okada T, Goto F, Ito S, Horiuchi Y, Kitano Y, Nishikawa H, Fujimoto M, Toma N (2024) Beneficial effects of Clazosentan add-on treatment on delayed cerebral microcirculatory disturbances after aneurysmal subarachnoid hemorrhage. Brain Hemorrhages 5:62\u201368. https:\/\/doi.org\/10.1016\/j.hest.2023.10.006","journal-title":"Brain Hemorrhages"},{"key":"3945_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.hest.2025.04.001","volume":"6","author":"H Suzuki","year":"2025","unstructured":"Suzuki H, Kawakita F, Aoki K, Hakozaki K (2025) Clazosentan for aneurysmal subarachnoid hemorrhage: update from Japan. Brain Hemorrhages 6:261\u2009\u2212\u2009264. https:\/\/doi.org\/10.1016\/j.hest.2025.04.001","journal-title":"Brain Hemorrhages"},{"key":"3945_CR34","doi-asserted-by":"publisher","first-page":"2391","DOI":"10.1161\/STROKEAHA.110.589275","volume":"41","author":"MD Vergouwen","year":"2010","unstructured":"Vergouwen MD, Vermeulen M, van Gijn J, Rinkel GJ, Wijdicks EF, Muizelaar JP, Mendelow AD, Juvela S, Yonas H, Terbrugge KG, Macdonald RL, Diringer MN, Broderick JP, Dreier JP, Roos YB (2010) Definition of delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage as an outcome event in clinical trials and observational studies: proposal of a multidisciplinary research group. Stroke 41:2391\u20132395. https:\/\/doi.org\/10.1161\/STROKEAHA.110.589275","journal-title":"Stroke"},{"key":"3945_CR35","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1001\/jamaneurol.2023.1792","volume":"80","author":"S Wolf","year":"2023","unstructured":"Wolf S, Mielke D, Barner C, Malinova V, Kerz T, Wostrack M, Czorlich P, Salih F, Engel DC, Ehlert A, Staykov D, Alturki AY, Sure U, Bardutzky J, Schroeder HWS, Sch\u00fcrer L, Beck J, Juratli TA, Fritsch M, Lemcke J, Pohrt A, Meyer B, Schwab S, Rohde V, Vajkoczy P, EARLYDRAIN Study Group (2023) Effectiveness of lumbar cerebrospinal fluid drain among patients with aneurysmal subarachnoid hemorrhage: a randomized clinical trial. JAMA Neurol 80:833\u2013842. https:\/\/doi.org\/10.1001\/jamaneurol.2023.1792","journal-title":"JAMA Neurol"},{"key":"3945_CR36","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.wneu.2012.09.020","volume":"81","author":"H Yoneda","year":"2014","unstructured":"Yoneda H, Shirao S, Nakagawara J, Ogasawara K, Tominaga T, Suzuki M (2014) A prospective, multicenter, randomized study of the efficacy of eicosapentaenoic acid for cerebral vasospasm: the EVAS study. World Neurosurg 81:309\u2013315. https:\/\/doi.org\/10.1016\/j.wneu.2012.09.020","journal-title":"World Neurosurg"},{"key":"3945_CR37","doi-asserted-by":"publisher","first-page":"679","DOI":"10.2176\/nmc.51.679","volume":"51","author":"J Zhao","year":"2011","unstructured":"Zhao J, Zhou D, Guo J, Ren Z, Zhou L, Wang S, Zhang Y, Xu B, Zhao K, Wang R, Mao Y, Xu B, Zhang X, Fasudil Aneurysmal Subarachnoid Hemorrhage Study Group (2011) Efficacy and safety of fasudil in patients with subarachnoid hemorrhage: final results of a randomized trial of fasudil versus nimodipine. Neurol Med Chir (Tokyo) 51:679\u2013683. https:\/\/doi.org\/10.2176\/nmc.51.679","journal-title":"Neurol Med Chir (Tokyo)"}],"updated-by":[{"DOI":"10.1007\/s10143-026-04302-0","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T00:00:00Z","timestamp":1777334400000}}],"container-title":["Neurosurgical Review"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10143-025-03945-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10143-025-03945-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10143-025-03945-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T13:04:16Z","timestamp":1777381456000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10143-025-03945-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,21]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3945"],"URL":"https:\/\/doi.org\/10.1007\/s10143-025-03945-9","relation":{},"ISSN":["1437-2320"],"issn-type":[{"value":"1437-2320","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,21]]},"assertion":[{"value":"1 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 November 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 November 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 November 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2026","order":6,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":7,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original online version of this article was revised: The authors regret that that the versions of Tables 4 and 5 that appeared in the original published article are incorrect. The correct and incorrect version of these tables are shown in the erratum article. The original article online has been corrected.","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2026","order":9,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":10,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":11,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s10143-026-04302-0","URL":"https:\/\/doi.org\/10.1007\/s10143-026-04302-0","order":12,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Dr. Suzuki reported personal fees from Eisai, Kowa, Otsuka and Nxera Pharma, and a research fund from Japan Blood Products Organization and Nxera Pharma outside the submitted work. The other authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. The study was approved by the ethical committee of Mie University Hospital (May 14, 2013; approval No. 2544, and September 6, 2018; approval No. H2018-031).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial number"}},{"value":"The ethical committee waived the need for informed consent with opt-out.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}}],"article-number":"19"}}